trending Market Intelligence /marketintelligence/en/news-insights/trending/jd0IQ-XDJgBZePSZaYCKGg2 content esgSubNav
In This List

Eleven Biotherapeutics receives Nasdaq noncompliance notice

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Eleven Biotherapeutics receives Nasdaq noncompliance notice

Eleven Biotherapeutics Inc. received a notice from the Nasdaq Stock Market LLC for failing to meet the $1 minimum bid price listing requirement.

The company has 180 days or until June 11, 2018, to regain compliance.

To regain compliance, the closing bid price of the company's common stock must meet or exceed $1 per share for a minimum of 10 consecutive business days during the 180-day period.